Mebendazole chewable tablets - Janssen

Drug Profile

Mebendazole chewable tablets - Janssen

Alternative Names: Vermox

Latest Information Update: 31 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Janssen
  • Class Anthelmintics; Benzimidazoles; Carbamates
  • Mechanism of Action Tubulin polymerisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Helminthiasis
  • New Molecular Entity No

Highest Development Phases

  • Registered Helminthiasis

Most Recent Events

  • 30 Oct 2017 Janssen's mebendazole chewable tablets (500mg) are available for Helminthiasis as part of global product donation programme and are not intended for commercial sale
  • 04 Aug 2017 Chemical structure information added
  • 13 Jun 2017 Registered for Helminthiasis in USA (PO, 100 mg)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top